| LH and hCG action on the same receptor results in quantitatively and qualitatively different intracellular signalling L Casarini, M Lispi, S Longobardi, F Milosa, A La Marca, D Tagliasacchi, ... Public Library of Science 7 (10), e46682, 2012 | 297 | 2012 |
| Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study E Villa, R Critelli, B Lei, G Marzocchi, C Cammà, G Giannelli, P Pontisso, ... Gut 65 (5), 861-869, 2016 | 259 | 2016 |
| Liver Angiopoietin‐2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct‐Acting Antivirals F Faillaci, L Marzi, R Critelli, F Milosa, F Schepis, E Turola, S Andreani, ... Hepatology 68 (3), 1010-1024, 2018 | 133 | 2018 |
| Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis E Turola, S Petta, E Vanni, F Milosa, L Valenti, R Critelli, L Miele, L Maccio, ... Disease models & mechanisms 8 (9), 1037-1046, 2015 | 101 | 2015 |
| Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study R Critelli, F Milosa, F Faillaci, R Condello, E Turola, L Marzi, B Lei, F Dituri, ... Cell Death & Disease 8 (8), e3017-e3017, 2017 | 59 | 2017 |
| Obese zebrafish: a small fish for a major human health condition F Faillaci, F Milosa, RM Critelli, E Turola, F Schepis, E Villa Animal Models and Experimental Medicine 1 (4), 255-265, 2018 | 46 | 2018 |
| Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma L Di Marco, A Pivetti, FG Foschi, R d’Amico, F Schepis, C Caporali, ... Liver Transplantation 29 (5), 559-563, 2023 | 16 | 2023 |
| AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) A Alisi, C Balsano, V Bernabucci, A Berzigotti, M Brunetto, E Bugianesi, ... Digestive and liver disease 48 (8), 860-868, 2016 | 10 | 2016 |
| Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation S Lasagni, F Leonardi, A Pivetti, L Di Marco, F Ravaioli, M Serenari, ... Frontiers in Oncology 12, 960808, 2022 | 6 | 2022 |
| Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma-and Intrahepatic Cholangiocarcinoma-Derived Spheroids A Romanzi, F Milosa, G Marcelli, RM Critelli, S Lasagni, I Gigante, F Dituri, ... Biomedicines 12 (1), 87, 2023 | 4 | 2023 |
| Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV‑positive women with hepatocellular carcinoma RM Critelli, F Milosa, A Romanzi, S Lasagni, G Marcelli, L Di Marco, ... Oncology letters 24 (5), 1-10, 2022 | 3 | 2022 |
| Prognostic significance of hypoxic and metabolic gene profiling in hepatocellular carcinoma F Milosa, RM Critelli, S Lasagni, A Pivetti, L Di Marco, D Romagnoli, ... Liver Cancer International 2 (1), 15-26, 2021 | 2 | 2021 |
| Lactosylated arginine-dehydrophenylalanine nanoparticles increase the selective delivery of miR-199a-3p to liver tumor cells enhancing antitumoral activity F Milosa, F Faillaci, R Critelli, E Villa Non-coding RNA Investigation 2, 2018 | 2 | 2018 |
| 1303 DIET-INDUCED OBESITY (DIO) AND STEATOSIS MODEL IN ZEBRAFISH: CHARACTERIZATION OF LIVER DAMAGE IN A GENDER AND AGE PERSPECTIVE E Turola, R Critelli, N Raos, S Mercorella, F Milosa, E Villa Journal of Hepatology, S526, 2013 | 2 | 2013 |
| Safety and clinical activity of combination treatment with regorafenib and milciclib in liver transplant patients with hepatocellular carcinoma recurrence. A Pivetti, L Di Marco, L Bristot, F Milosa, RM Critelli, N De Maria, ... Journal of Clinical Oncology 38 (15_suppl), e16634-e16634, 2020 | 1 | 2020 |
| Overfeeding accelerates thioacetamide-induced liver damage in zebrafish E Turola, F Milosa, R Critelli, M di Giovanni, F Cotelli, E Villa | 1 | 2015 |
| The Neoangiogenic Transcriptomic Signature Impacts Hepatocellular Carcinoma Prognosis and Can Be Triggered by Transarterial Chemoembolization Treatment RM Critelli, F Casari, A Borghi, G Serino, C Caporali, P Magistri, A Pecchi, ... Cancers 16 (20), 3549, 2024 | | 2024 |
| Differential Impact of Tumor Endothelial Angiopoietin-2 and Podoplanin in Lymphatic Endothelial Cells on HCC Outcomes with Tyrosine Kinase Inhibitor Treatment According to Sex S Lasagni, RM Critelli, F Milosa, D Saltini, F Schepis, A Romanzi, F Dituri, ... Biomedicines 12 (7), 1424, 2024 | | 2024 |
| Abstract PO008: Aggressive hepatocellular carcinoma and intrahepatic cholangiocarcinoma cell lines share similar response to proangiogenic priming F Milosa, A Romanzi, G Marcelli, RM Critelli, S Lasagni, M Cadamuro, ... Clinical Cancer Research 28 (17_Supplement), PO008-PO008, 2022 | | 2022 |
| Neoangiogenic transcriptomic signature identifies HCCs with worse response to treatment: long-term results of a prospective study A Pivetti, A Borghi, R Critelli, B Lei, F Casari, M Del Buono, F Milosa, ... Digestive and Liver Disease 52, e11-e12, 2020 | | 2020 |
